San Francisco – October 15, 2026 -- Benchling launched Science Foundries, a product that lets R&D teams run entire scientific processes with agents and scientists working from the same data, and made it available to its customers the same day.

Teams select a process or goal, such as producing proteins, optimizing a lead or improving a manufacturing process. They then define which steps agents run and where scientists must approve. Agents execute and monitor work, coordinate handoffs and flag key decisions to scientists.

Toronto – October 15, 2026 -- PointClickCare has appointed Armughan Ahmad, former chief executive of AI data company Appen (ASX: APX), to its board of directors as the health tech company pushes an AI-first strategy, while Rob Eberle steps down after more than 11 years on the board.

Indianapolis – October 15, 2026 -- More than one in four ulcerative colitis (UC) patients (27.7%) treated with Eli Lilly and Company's Omvoh (mirikizumab-mrkz) achieved comprehensive disease control at one year, compared with 14% on placebo, according to a post hoc analysis of the LUCENT-2 trial.

In the VIVID-1 Crohn's disease trial, 20.4% of Omvoh-treated patients reached corticosteroid-free deep remission, versus 2% on placebo. Lilly will present both analyses at United European Gastroenterology (UEG) Week 2026.

Cambridge, Mass. – October 15, 2026 -- The U.S. Food and Drug Administration has granted a second Fast Track Designation to Marengo Therapeutics' invikafusp alfa, extending the drug's expedited status from one tumor type to all tumor mutational burden high (TMB-H) solid tumors regardless of tissue of origin.

Friendswood, Texas – October 15, 2026 -- Castle Biosciences (Nasdaq: CSTL) will release its financial results for the third quarter and nine months ended Sept. 30, 2026, after the close of market on Thursday, Nov. 5, 2026.

Management hosts webcast at 4:30 p.m. Eastern on Nov. 5

Company management will discuss the results on a live webcast at 4:30 p.m. Eastern time on the same day. A brief question-and-answer session will follow management's commentary.

Taipei – October 15, 2026 -- MetaTech AP Inc. (TPEx: 3224) reported revenue of NT$1.391 billion for the first nine months of 2026, up 21% year over year. The company outlined its 2027 strategy at an investor conference, with electronics and biomedicine as its two growth engines.

New York – – October 15, 2026 -- Expert Consumers has named Sharps Assure a top choice for veterinary clinics, citing flat-rate mail-back kits, container sizes from 1 quart to 28 gallons, and no required long-term contracts. The review is published on an affiliate site that may earn commissions from sales made through its links.

Stockholm – October 15, 2026 -- The US National Institutes of Health (NIH) has selected SciBase Holding AB's Nevisense electrical impedance spectroscopy (EIS) technology as the primary endpoint in its THREAT study, which will test how environmental exposures affect the skin barrier in 80 healthy volunteers.

Paris – October 14, 2026 -- The share of patients reporting sleep difficulties fell by 59%, 56% and 55% within 48 hours of starting Mucosolvan or Bisolvon, according to a new real-world study from Opella on acute chesty cough.

Sleep complaints drop across three categories within 48 hours

The percentage of patients reporting difficulty falling asleep fell by 59%. Those reporting difficulty staying asleep fell by 56%, and those reporting sleep-related tiredness by 55%. Opella describes sleep disruption as a primary patient concern.

Las Vegas – October 14, 2026 -- SpectroChip Inc. has committed NT$3 million (about US$94,000) over five years to Kaohsiung Municipal Siaogang Hospital under a collaboration with OTC-listed PurMinds Enterprises, Inc. (PFSF) to validate point-of-care (POC) diagnostic technologies.